Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

biogen_austria_238

George Scangos to step down as Biogen CEO

July 21, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Biogen, George Scangos

In a surprising move, Biogen used the publishing of some promising second quarter results to announce the departure of CEO …
News

AstraZeneca’s Zavicefta meets primary endpoint in Phase III pneumonia trials

July 21, 2016 Research and Development Antibiotics, AstraZeneca, zavifecta

AstraZeneca has announced results from a Phase III trial for its recently approved antibiotic, Zavicefta (ceftazidime-avibactam), which met its primary …
News
dollars_medicines

Galenica announces $1.53 billion Replysa acquisition

July 21, 2016 Research and Development, Sales and Marketing Relypsa, Vifor pharma, galenica

Galenica has announced that it has entered into an agreement to acquire Relypsa in a deal worth $1.53 billion, which …
News
roche_dark_0

Roche beats forecasts in strong H1 results

July 21, 2016 Research and Development, Sales and Marketing 2016, Q2, Roche, h1, results

Roche has published very encouraging full results for the first half of this year, with cancer drug sales helping to …
News
test_results

Zafgen ends lead drug development, shares plummet

July 21, 2016 Research and Development zafgen

Zafgen has announced that it has dropped development of its lead drug candidate, beloranib, in order to focus on a …
News
lab

NICE recommends PTC Therapeutics Duchenne muscular dystrophy treatment

July 20, 2016 Research and Development, Sales and Marketing Duchenne Muscular Dystrophy, PTC Therapeutics

PTC Therapeutics has announced that the National Institute for Health and Care Excellence has issued final guidance recommending Translarna (ataluren) …
News
astrazeneca_crestor_rosuvastatin_40mg

AstraZeneca loses legal bid to block Crestor generics

July 20, 2016 Research and Development, Sales and Marketing AstraZeneca, Crestor, FDA, generics, legal

A US district court judge has refused AstraZeneca’s request for a temporary restraining order blocking the approval of generic versions …
News
jj_sign_on_wall

J&J boosted by pharma revenue in Q2 results

July 20, 2016 Research and Development 2016, Johnson and Johnson, Q2, results

Shares at Johnson and Johnson have reached a record high of over $125 after pharma revenues helped to raise full …
News

Bristol-Myers Squibb settle $30 million California kickback lawsuit

July 20, 2016 Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, california, lawsuit

Bristol-Myers Squibb (BMS) has agreed to pay $30 million to the California Department of Insurance to settle an almost decade …
News
doc_writing

FDA panel unanimously recommends approval of Valeant’s brodalumab with conditions

July 20, 2016 Research and Development, Sales and Marketing FDA, Valeant, brodalumab

Valeant has announced that the US Food and Drug Administration’s (FDA) dermatologic and ophthalmic drugs advisory committee has recommended brodalumab …
News
celgene_1_02

Celgene boosts cancer portfolio with deal worth up to $2.5 billion with Jounce Therapeutics

July 19, 2016 Research and Development, Sales and Marketing Celgene, jounce

Celgene has entered into a collaboration with Jounce Therapeutics that will see the pair jointly develop and commercialise Jounce’s lead …
News
opdivo_1

Opdivo to go before EU, US regulators in head and neck cancer

July 19, 2016 Manufacturing and Production, Research and Development EMA, EU, FDA, US, head and neck cancer, opdivo

Bristol-Myers Squibb has announced that its lead oncology drug, Opdivo (nivolumab), is set to go before regulators in the US …
News
novartis_side_building

Novartis lowers core operating profit outlook in Q2 results

July 19, 2016 Manufacturing and Production, Research and Development, Sales and Marketing 2016, Novartis, Q2, results

Novartis has warned that its profits may decline this year as it issued second quarter results, with generic competition for …
News
triumeq-image-pill-bottle

New data shows superior viral suppression for Triumeq in women with HIV

July 18, 2016 Manufacturing and Production, Research and Development Triumeq, ViiV Healthcare

ViiV Healthcare has presented late-stage data showing superior efficacy for combination treatment Triumeq (dolutegravir/abacavir/lamivudine) compared with atazanavir, plus other treatments, …
News
astrazeneca-sign

AstraZeneca presents positive Phase III results for lung cancer drug Tagrisso

July 18, 2016 Manufacturing and Production, Research and Development AstraZeneca, Tagrisso

AstraZeneca has presented results from the latest Phase III trial evaluating Tagrisso (osimertinib) as a second line treatment for patients …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026